AI-DERIVED AUTOMATED QUANTIFICATION OF CARDIAC CHAMBERS AND MYOCARDIUM FROM NON-CONTRAST CT: PREDICTION OF ADVERSE CARDIOVASCULAR EVENTS IN ASYMPTOMATIC SUBJECTS
Therapeutic Area: ASCVD/CVD Risk Assessment Background: The significance of myocardial mass and chamber volumes from non-contrast computed tomography (CT) for predicting major adverse cardiovascular events (MACE) has not been studied. Our objective was to evaluate the role of artificial intelligence...
Saved in:
Main Author: | |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_1d25adf2dea04a4a869aceed4f30a1b8 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Aryabod Razipour, MD |e author |
245 | 0 | 0 | |a AI-DERIVED AUTOMATED QUANTIFICATION OF CARDIAC CHAMBERS AND MYOCARDIUM FROM NON-CONTRAST CT: PREDICTION OF ADVERSE CARDIOVASCULAR EVENTS IN ASYMPTOMATIC SUBJECTS |
260 | |b Elsevier, |c 2024-09-01T00:00:00Z. | ||
500 | |a 2666-6677 | ||
500 | |a 10.1016/j.ajpc.2024.100850 | ||
520 | |a Therapeutic Area: ASCVD/CVD Risk Assessment Background: The significance of myocardial mass and chamber volumes from non-contrast computed tomography (CT) for predicting major adverse cardiovascular events (MACE) has not been studied. Our objective was to evaluate the role of artificial intelligence-enabled multi-chamber cardiac volumetry from non-contrast CT for long-term risk stratification in asymptomatic subjects without known coronary artery disease. Methods: Our study included 2022 asymptomatic individuals (55.6±9.0 years; 59.2% male) from the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) trial. The multi-chamber cardiac volumetry was performed using deep-learning algorithms from routine non-contrast CT scans for coronary artery calcium scoring. MACE was defined as myocardial infarction, late (>180 days) revascularization, and cardiac death. Results: A total of 215 individuals (11%) suffered MACE at a mean follow-up of 13.9±3 years. Individuals with MACE, as compared to those without MACE, had higher left ventricle (LV) myocardial mass (118.1 g vs 106.9 g, p<0.001) and higher LV chamber volume (105.0 cm3 vs. 96.9 cm3, p<0.001). In multivariable logistic regression, LV myocardial mass (HR 1.19[95% CI 1.04-1.36] per standard deviation) and left ventricular volume (HR 1.16 [95% CI 1.02-1.32] per standard deviation) were independent predictors of MACE. Patients with the highest LV myocardial mass (> 118.1 g) and chamber (> 105.0 cm3) volume, as divided into tertiles, presented a steep increase in the risk of MACE (log rank p<0.001). Conclusions: LV volume and myocardial mass quantified automatically by AI from routine non-contrast CT independently predicted long-term MACE risk in asymptomatic patients without known coronary artery disease. AI-derived LV measurements from routine non-contrast cardiac CT without physician interaction may improve the risk stratification of MACE. | ||
546 | |a EN | ||
690 | |a Diseases of the circulatory (Cardiovascular) system | ||
690 | |a RC666-701 | ||
690 | |a Public aspects of medicine | ||
690 | |a RA1-1270 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n American Journal of Preventive Cardiology, Vol 19, Iss , Pp 100850- (2024) | |
787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2666667724002186 | |
787 | 0 | |n https://doaj.org/toc/2666-6677 | |
856 | 4 | 1 | |u https://doaj.org/article/1d25adf2dea04a4a869aceed4f30a1b8 |z Connect to this object online. |